GABY Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Simon Lileikis
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Address
- 200, 209-8th Avenue SW Calgary AB Canada T2P 1B8
- IPO Date
- Oct 29, 2018
- CIK
- 0001783713
- Website
- gabyinc.com
- Similar Companies
- Business
- GABY Inc. (CSE: GABY; OTCQB: GABLF) produces, markets, sells and retails cannabis-related consumer packaged goods with a retail focus in California; the company offers a portfolio of branded products including flower, concentrates, pre-rolls, edibles, topicals, tinctures and other cannabis- or hemp-infused items under the Kind Republic, Mankind, Lulu’s, 2Rise, Dank Space, Sonoma Pacific, HempFusion, Sagely Naturals and Apothecanna brands; it operates the flagship Mankind Dispensary in San Diego, which features hands-on service without glass barriers, robust delivery and curbside pickup programs, and stocks over 700 unique products. GABY Inc. was incorporated in 2003 as Gabriella's Kitchen Inc., changed its name to GABY Inc. in September 2019, and is headquartered in Calgary, Canada, with principal operations in San Diego, California. The company pursues vertical integration by owning significant supply channels including manufacturing, distribution and cultivation capabilities to serve recreational and medical cannabis consumers through its dispensary and wholesale distribution across California. Recent major developments include the 2021 merger with Miramar Professional Services to acquire Mankind Dispensary as the foundation for retail expansion targeting up to 100 locations; a US$12.5 million financing completed in connection with the acquisition; strategic acquisitions of CBD brands HempFusion, Sagely Naturals and Apothecanna; and the launch of new house brands such as Dank Space indica flower, which became the best-selling product at Mankind Dispensary.
GABY Announces Winding Down of Operations
GABY Exercises the Reversion Remedy and Forfeits the Shares It Holds in Miramar Professional Services in Exchange for Release of $22.5 Million Debt
GABY Inc. Leadership Team Steers San Diego's Mankind Dispensary Towards Major Operation, Cultural, and Community Impact Improvements
GABY Inc. Congratulates Board Member Javier Estades on Being Named Chairman of the Cigar Association of America
GABY Inc. Joins The Stock Day Podcast to Discuss their Strategy to Consolidate Cannabis Dispensaries
Gaby Inc Announces Engagement with Veteran Firm Hybrid Financial Ltd., to Help Get the GABY Story Out to New Investors and Interested Parties
GABY Owned Mankind Dispensary Joins Inc. Magazine's 2021 List of America's Top 5,000 Growing Companies
GABY Inc. Reports Q2 2021 Record Revenue of $11.3MM and a Gross Profit Margin of 35%
GABY Signs 20-Year Veteran Executive Marshall Minor as Chief Financial Officer and Continues to Consolidate its Asset Base and Realize Synergies within its California Operations
GABY Inc. Further Strengthens its Board of Directors with the Appointment of Loreto Grimaldi
GABY Inc. Discusses Mankind Merger and Launch of Kind Republic Cannabis Brand with The Stock Day Podcast
Gaby Inc. Reports Q1 2021 Revenue of $3.4MM and Record First Quarter 2021 Pro Forma Revenue of $12.3MM